Dow Up 1.30% Nasdaq Up 0.37%

Novavax, Inc. (NVAX)

-NasdaqGS
5.63 Up 0.22(4.07%) Oct 30, 4:00PM EDT
|After Hours : 5.63 0.00 (0.00%) Oct 30, 7:17PM EDT
Prev Close:5.41
Open:5.74
Bid:5.53 x 1000
Ask:N/A
1y Target Est:10.07
Beta:1
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:5.56 - 5.75
52wk Range:2.68 - 6.95
Volume:6,227,836
Avg Vol (3m):3,836,480
Market Cap:1.34B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXUp 4.07%1.34B
MRKUp 1.98%165.32B
NVSUp 0.70%222.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):44.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback